It means a great deal to us to have strong relationships with Pharmaceutical and Biotech companies who are working in Alagille Syndrome and other related fields. We have had intricate involvement in the drug development process of two FDA approved drugs for cholestatic liver disease pruritus from start to finish including initial phases, clinical trial, expanded access, and public approval. We played a big role in patient recruitment and continue to guide patients to drug access pathways. We celebrate companies who have worked behind the scenes in drug development and partner to shed light on the impacts to the rare disease communities they serve. Further involvement includes guidance in the development of patient resources and programs, recruitment of patients and caregivers for research intitiatives, family experiences, and patient stories. Elevating the patient voice is our job and we work hard to do that in whatever capacity we can to help pharma and biotech achieve their goals while striving to meet our mission.